TradingView
MarketMoversReport
Mar 29, 2022 4:02 PM

Antares Pharma Announces FDA Approval Of TLANDO Long

NASDAQ:ATRS1D

Description

⋅
ATRS: Antares Pharma, Inc.
2022-03-29 07:00:00
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
Beyond Technical Analysis
More